RxDoctor Payments Data

Thomas Chirichella, MD

Transplant Surgery · Youngstown, OHNPI 1548577596

Payments from drug & device makers

What this record shows

This record is dominated by education: $3,000 of the $4,932 with a category attached, or 60.8%. Intuitive Surgical accounts for 69.7% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2020 at $3,064 and has fallen 80.1% since, to $610 in 2025.

$4,932in general payments, 2019–2025

Across 70 payments — averaging $70.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$3K
  • AbbVie$525
  • Dilon Technologies, Inc.$391
  • Intera Oncology, Inc$165
  • Sirtex Medical Inc$155
  • Biom'up France SAS$59
  • plus $199 from 8 others

What the payments were for

  • Food & beverage$1,93239%
  • Education$3,00061%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,932 in reported general payments places this provider in the 70th percentile of 43 transplant surgery providers in Ohio.

See all transplant surgery providers in Ohio

Medicare billing

Part B allowed, 2024
$78,061
Medicare patients
211
Services billed
475

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase188$514,962
Ursodiol16$1,192
Famotidine35$700
Pantoprazole Sodium84$612
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen47$308
Prednisone19$70
Diazepam21$14

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieCreon$525$514,962188 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 43 transplant surgery providers in Ohio.

Other transplant surgery in Youngstown

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →